Chat with us, powered by LiveChat

Ep 40: Take Action Today! Advocate Against 2024 Medicare Cuts

Take Action Today! Advocate Against 2024 Medicare Cuts

Over the past couple of years we have routinely seen reductions in reimbursement underneath the Medicare Physician Fee Schedule (MPFS) and this year is no different. While AOTA is working diligently to advocate for our profession, your voice matters! Writing letters to Congress plays an important role in the legislative process of passing policy in the United States. That’s why this week on The Amplify OT Podcast, I am talking about why you need to take action today and advocate against Medicare cuts!

Join the Amplify OT Membership

As an exclusive bonus for podcast listeners, you can join the Amplify OT Membership at any time! Join today to take control of your career! It’s time to become your own best resource on Medicare and advocacy.

In this episode, I cover:

  • The 3.4% reduction we’re looking at in 2024 under the MPFS if no action is taken. 
  • How AOTA makes it quick and simple to write a letter to your legislators and be an OT Amplifier. 
  • Encouraging you to edit your letters and share personal stories of impact.
  • The different pieces of legislation being brought to Congress and the solutions they are proposing.

❗ Tune into the next episode of the Amplify OT Podcast to get deeper into the weeds of why we continue to see cuts year after year.

Amplify OT Resources

Want to keep learning about how insurance and reimbursement impact you? Then head to to see what resources we have available!




©Amplify OT

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top
Tech display of the Amplify OT Membership showing our course page, groups, and activity feed.

Oh no! ☹️
Sign ups aren't currently open right now - Get on the waitlist by entering your info below.
We'll let you know when doors open again so you get access ASAP!

We use cookies to ensure you receive the best experience on our site. If you continue to use this site, we assume you agree with our terms.